祥翊(6676)今(16)日表示，开发中抗癌用药TMN-T及溃疡性结肠炎用药MSL-T已于本月先后与S公司签订美国市场专属授权合约。祥翊可依这2项药物的开发进度，收取签约金与阶段里程碑金等合计达260万美元(约新台币8,320万元) ...
In response to the challenge, the carriers and international standards bodies have defined a solution called the Telecommunications Management Network (TMN), which consists of a series of interrelated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback